Sign In
9 Jan 2009 10:23
ο»Ώ
Ark Therapeutics Group plc
2009
Notification of Major Interests in Shares
Β 1Β Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
ARK THERAPEUTICS GROUP PLC
2.Β Reason for the notification (please tick the appropriate box or boxes):
|
An acquisition or disposal of voting rights: |
(x) |
|
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
( ) |
|
An event changing the breakdown of voting rights: |
( ) |
|
Other |
( ) |
3.Β Full name of person(s) subject to the notification obligation:
Invesco Limited
4.Β Full name of shareholder(s) (if different from 3):
5.Β Date of the transaction and date on which the threshold is crossed or reached if different:
5 January 2008
6.Β Date on which issuer notified:
8 January 2008
Β
7.Β Threshold(s) that is/are crossed or reached:
10%
8.Β Notified details:
A:Β Voting rights attached to shares
|
Class/type of shares: |
Ordinary 1p shares GB0034251727 |
|
Situation previous to the triggering transaction: |
|
|
Number of shares: |
17,454,451 |
|
Number of voting rights: |
17,454,451 |
|
Resulting situation after the triggering transaction: |
|
|
Number of shares: |
20,838,839 |
|
Number of voting rights:Β |
|
|
Direct: |
|
|
Indirect: |
20,838,839 |
|
% of voting rights: |
|
|
Direct: |
|
|
Indirect: |
10.15% |
B:Β Financial Instruments:
Resulting situation after the triggering transaction:
Type of financial instrument:
Expiration date:
Exercise/conversion period/date:
Β
Number of voting rights that may be acquiredΒ if the instrument is exercised/ converted:
% of voting rights:
Total (A+B):
|
Number of voting rights: 20,838,839 |
20,838,839 |
|
% of voting rights: 10.15% |
10.15% |
Β
9.Β Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
|
Brown Brothers Harriman (New Jersey) |
36,859 |
|
JP Morgan Chase |
2,963,208Β |
|
Citibank |
17,838,772 |
Proxy Voting:
10.Β Name of the proxy holder:
11.Β Number of voting rights proxy holder will cease to hold:
12.Β Date on which proxy holder will cease to hold voting rights:
13.Β Additional information:
14.Β Contact name:
Sam Edwards
15.Β Contact telephone number:
01491 416381
16. Contact name and telephone at issuer:
Martyn Williams
Company Secretary
Ark Therapeutics Group plc
Β
020 7388 7722
9 January 2009
END
Follow the stocks
